From Merck & Co to Sanofi, Pharmaceutical Technology lists the leading pharmaceutical companies spending the most on R&D in ...

AstraZeneca has maintained that while the vaccine may, in “very rare” cases, cause TTS, the casual mechanism for this effect ...

Emergent also said it will shut down two of its US-based complexes – a drug substance manufacturing facility in Baltimore and ...

Bayer and Evotec have expanded collaboration to focus on the development of precision treatments for cardiovascular diseases ...

The updated identity is part of international sweeping changes by J&J as the big pharma unites its medtech and pharmaceutical ...

Dengue fever is now found in over 120 countries compared to nine that experienced severe epidemics in the 1970s given the ...

The sprinkle formulation of Ingrezza is approved as an alternative for Huntington’s patients who have difficulty swallowing.

Ono will gain access to Deciphera’s kinase inhibitor pipeline, which includes the CSF-1 inhibitor vimseltinib and ULK ...

Janssen-Cilag has sought expanded European Medicines Agency (EMA) approval for TREMFYA to treat active ulcerative colitis and ...

Pfizer’s reported net income stood at $3.11bn in Q1 2024, marking a decrease of 44% from $5.54bn posted in the same period of ...

AstraZeneca has recently announced that Fasenra has been approved for severe asthma, specifically for the eosinophilic ...

Eli Lilly has announced that its net income rose to $2.24bn in Q1 2024, a 67% increase from $1.34bn in the same period of ...